Increased bone marrow CD56(bright) natural killer cells at 30 days after allogeneic stem cell transplantation associated with adverse patient outcome

Wang Ren Ching; Mori Shahram; Zhu Xiang; Varela Juan Carlos; Dickman Debbie; Patel Rushang; Ward David; Goldstein Steven C.; Chang Chun-Che

首页> 外文期刊>Bone marrow transplantation >Increased bone marrow CD56(bright) natural killer cells at 30 days after allogeneic stem cell transplantation associated with adverse patient outcome

【24h】

Increased bone marrow CD56(bright) natural killer cells at 30 days after allogeneic stem cell transplantation associated with adverse patient outcome

机译：在与不良患者结果相关的同种异体干细胞移植后30天增加骨髓CD56（明亮）天然杀伤细胞

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Bone marrow transplantation》 |2019年第6期|共4页
作者
Wang Ren Ching; Mori Shahram; Zhu Xiang; Varela Juan Carlos; Dickman Debbie; Patel Rushang; Ward David; Goldstein Steven C.; Chang Chun-Che;
展开▼
作者单位

Florida Hosp Dept Pathol &

Lab Med Orlando FL USA;

Florida Hosp Blood &

Marrow Transplant Ctr Orlando FL 32803 USA;

Florida Hosp Res Analyt Inst Orlando FL USA;

Florida Hosp Blood &

Marrow Transplant Ctr Orlando FL 32803 USA;

Florida Hosp Dept Pathol &

Lab Med Orlando FL USA;

Florida Hosp Blood &

Marrow Transplant Ctr Orlando FL 32803 USA;

Florida Hosp Dept Pathol &

Lab Med Orlando FL USA;

Florida Hosp Blood &

Marrow Transplant Ctr Orlando FL 32803 USA;

Florida Hosp Dept Pathol &

Lab Med Orlando FL USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Increased bone marrow CD56(bright) natural killer cells at 30 days after allogeneic stem cell transplantation associated with adverse patient outcome [J] . Wang Ren Ching, Mori Shahram, Zhu Xiang, Bone marrow transplantation . 2019,第6期

机译：在与不良患者结果相关的同种异体干细胞移植后30天增加骨髓CD56（明亮）天然杀伤细胞
2. Non-CD34+ cells, especially CD8+ cytotoxic T cells and CD56+ natural killer cells, rather than CD34 cells, predict early engraftment and better transplantation outcomes in patients with hematologic malignancies after allogeneic peripheral stem cell t [J] . Kim DH, Won DI, Lee NY, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2006,第7期

机译：非CD34 +细胞，尤其是CD8 +细胞毒性T细胞和CD56 +自然杀伤细胞，而不是CD34细胞，可以预测异基因外周血干细胞移植后血液系统恶性肿瘤的早期植入和更好的移植结果
3. Expansion of cytotoxic CD56 bright natural killer cells during T-cell deficiency after allogeneic hematopoietic stem cell transplantation [J] . Gertjan Lugthart, Marieke Goedhart, Merle M. van Leeuwen, The Journal of Allergy and Clinical Immunology . 2017,第5期

机译：同种异体造血干细胞移植后T细胞缺乏的细胞毒性CD56明显自然杀伤细胞
4. Long-term outcome after bone marrow cell transplantation in patients with acute myocardial infarction [C] . I Zeus, M. Brehm, M. Kostering, Nordrhein-Westfa?lische Akademie der Wissenschaften . 2005

机译：骨髓细胞移植后急性心肌梗死患者的长期结果
5. Children with acute leukemia: A comparison of outcomes and cost-effectiveness from allogeneic blood stem cell and bone marrow transplantation. [D] . Lin, Yu-Feng. 2009

机译：儿童急性白血病：同种异体造血干细胞和骨髓移植的疗效和成本效益比较。
6. Increased Foxp3+Helios+ regulatory T cells and decreased acute graft-versus-host disease after allogeneic bone marrow transplantation in patients receiving sirolimus and RGI-2001 an activator of invariant natural killer T cells [O] . Yi-Bin Chen, Yvonne A. Efebera, Laura Johnston, -1

机译：接受西罗莫司和RGI-2001（不变的自然杀伤性T细胞的激活剂）的患者接受异基因骨髓移植后Foxp3 + Helios +调节性T细胞增加急性移植物抗宿主病减少
7. Non-CD34+ Cells, Especially CD8+ Cytotoxic T Cells and CD56+ Natural Killer Cells, Rather Than CD34 Cells, Predict Early Engraftment and Better Transplantation Outcomes in Patients with Hematologic Malignancies after Allogeneic Peripheral Stem Cell Transplantation [O] . Kim Dong Hwan, Won Dong Il, Lee Nan Young, 2006

机译：非CD34 +细胞，尤其是CD8 +细胞毒性T细胞和CD56 +自然杀伤细胞，比CD34细胞更能预测异基因外周血干细胞移植后血液系统恶性肿瘤的早期植入和更好的移植结果

Increased bone marrow CD56(bright) natural killer cells at 30 days after allogeneic stem cell transplantation associated with adverse patient outcome

著录项

相似文献

相关主题

期刊订阅